10x Genomics | 10-Q: Quarterly report
May 1 04:17
10x Genomics | 8-K: 10x Genomics Reports First Quarter 2024 Financial Results
May 1 04:12
10x Genomics | DEFA14A: Others
Apr 27 10:20
10x Genomics | DEF 14A: Definitive information statements
Apr 27 04:17
10x Genomics | PRE 14A: Preliminary proxy statements relating to merger or acquisition
Apr 13 04:28
10x Genomics | 4: Statement of changes in beneficial ownership of securities-Officer Hindson Benjamin J.
Mar 26 05:21
10x Genomics | 4: Statement of changes in beneficial ownership of securities-Officer Saxonov Serge
Mar 26 05:20
10x Genomics | 4: Statement of changes in beneficial ownership of securities-Officer McAnear Justin J.
Mar 26 05:20
10x Genomics | 4: Statement of changes in beneficial ownership of securities-Officer Saxonov Serge
Mar 19 07:06
10x Genomics | 4: Statement of changes in beneficial ownership of securities-Officer Saxonov Serge
Mar 7 05:16
10x Genomics | 144: Notice of proposed sale of securities pursuant to Rule 144
Mar 5 07:42
10x Genomics | 4: Statement of changes in beneficial ownership of securities-Officer Saxonov Serge
Feb 27 05:18
10x Genomics | 4: Statement of changes in beneficial ownership of securities-Officer Hindson Benjamin J.
Feb 27 05:17
10x Genomics | 4: Statement of changes in beneficial ownership of securities-Officer McAnear Justin J.
Feb 27 05:16
10x Genomics | 144: Notice of proposed sale of securities pursuant to Rule 144
Feb 23 08:22
10x Genomics | 144: Notice of proposed sale of securities pursuant to Rule 144
Feb 23 08:07
10x Genomics | 144: Notice of proposed sale of securities pursuant to Rule 144
Feb 23 08:03
10x Genomics | 4: Statement of changes in beneficial ownership of securities-Officer Saxonov Serge
Feb 21 05:25
10x Genomics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Feb 16 06:38
10x Genomics | 10-K: Annual report
Feb 16 06:18
No Data
No Data